Trump's Trade Winds: Navigating the Storm for India's Pharma Giants
Navigating the Trade Tempest: India and US Seek Common Ground Amidst Tariffs and Tensions
Indian Pharma Sector Poised for Massive Rs 45,000 Crore Investment Boom by FY26, ICRA Reports
India's 'Pharmacy of the World' Title at Risk: Urgent GST Reforms Needed for Pharma Exports